Anton Bennett

Professor

Yale University School of Medicine

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Anton Bennett is a Professor at Yale School of Medicine, located in the United States. His research primarily focuses on the roles of MAP Kinase Phosphatases in health and disease, as well as their implications in various conditions such as non-alcoholic fatty liver disease and heart disease. Recent publications highlight his work on the modulation of endurance exercise capacity, fibrosis, and therapeutic landscape for RASopathies.

Articles (15)

Year:

2025

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (9)

Elizabeth Pierpont

University of Minnesota

UNITED STATES

View details

Emilia Galperin

Professor

University of Kentucky

UNITED STATES

View details

Maija Kiuru

UNITED STATES

View details

Cheng Zhang

University of Texas Southwestern Medical Center

UNITED STATES

View details

Karin Walsh

Assistant Professor/Pediatric Neuropsychologist

Children's National Health System

UNITED STATES

View details

Maria Kontaridis

Executive Director, Gordon K Moe Professor

UNITED STATES

View details

Pau Castel

Assistant Professor

New York University Grossman School of Medicine

UNITED STATES

View details

Beth Stronach

University of Pittsburgh

UNITED STATES

View details

Shruti Garg

Senior Lecturer

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Anton Bennett

Research Interests

Explore related searches

Contact this professor

About

Articles (15)

MAP Kinase Phosphatase-5 Deficiency Improves Endurance Exercise Capacity

Hepatocyte-specific miR-33 deletion attenuates NAFLD-NASH-HCC progression

MAP Kinase Phosphatases as Nodal Signal Regulators in Health and Disease

Mitogen-Activated Protein Kinase Phosphatases: No Longer Undruggable?

SH2 Domain-Containing Phosphatase-SHP2 Attenuates Fibrotic Responses through Negative Regulation of Mitochondrial Metabolism in Lung Fibroblasts

Teaching an old dog new tricks: A new tool for protein tyrosine phosphatase substrate discovery

The seventh international RASopathies symposium: Pathways to a cure-expanding knowledge, enhancing research, and therapeutic discovery.

An Assessment of the Therapeutic Landscape for the Treatment of Heart Disease in the RASopathies

Defining the structure-activity relationship for a novel class of allosteric MKP5 inhibitors

Lack Of Map Kinase Phosphatase-5 In Macrophages Protects Ldlr-null Mice Against Atherogenesis

MAP Kinase Phosphatase-5 Deficiency Protects Against Pressure Overload-Induced Cardiac Fibrosis.

Low-dose Dasatinib Ameliorates Hypertrophic Cardiomyopathy in Noonan Syndrome with Multiple Lentigines

The sixth international RASopathies symposium: Precision medicine—From promise to practice

An allosteric site on MKP5 reveals a strategy for small-molecule inhibition

Tyrosyl phosphorylation of PZR promotes hypertrophic cardiomyopathy in PTPN11-associated Noonan syndrome with multiple lentigines

Collaborators (9)

Elizabeth Pierpont

Emilia Galperin

Maija Kiuru

Cheng Zhang

Karin Walsh

Maria Kontaridis

Pau Castel

Beth Stronach

Shruti Garg

Make your next move.